Product Ref: BIEMB00 Category: Prescriptions
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-VPS |
Temperature | Ambient |
MA/VM/EU No: | 50146/4014 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/ProductInformationDatabase/product/A006318 |
NOAH Link | https://www.noahcompendium.co.uk/?id=-447027 |
Dosage | Amounts to be administered and administration route Control and treatment of Strongyles, Oxyuris and Parascaris: Embotape should be used at a dose rate of 19 mg pyrantel embonate per kg bodyweight. The prescribed amount of Embotape is deposited on the tongue of the animal and the animal allowed to swallow. The complete contents of one syringe contains 11.4g pyrantel embonate (6 graduated doses of 1.9g) in 28.5g paste and is sufficient for the treatment of 600kg bodyweight. Each graduation of the syringe is sufficient for the treatment of 100kg body-weight. Control and treatment of Anoplocephala (Tapeworm): Embotape should be used at a dose rate of 38mg pyrantel embonate per kg bodyweight (i.e. twice the dose used for stronglyes). The need for re-treatment may vary, but if considered necessary, should be carried out after an interval of 6 weeks. To ensure administration of a correct dose, body weight should be determined as accurately as possible. Overdose Pyrantel embonate is of low oral toxicity. Oral doses of up to 2000mg/kg bodyweight in mice and rats and 1000mg/kg in dogs have produced no evidence of toxicity. Pyrantel embonate, at dosages of up to 60mg/kg bodyweight (20 times the standard therapeutic dose) had no adverse effects on horses, ponies or foals. Monitoring included haematological parameters, and serum cholinesterase and glutamic oxaloacetic transaminase levels. |
Withdrawals | Withdrawal periods Not to be used in horses and ponies intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation. |